Phase II Clinical Study of Lapatinib (GW572016) in Patients With ErbB2 Over - Expressing Advanced or Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 13 May 2013
At a glance
- Drugs Lapatinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 24 Mar 2010 Actual patient number (62) added as reported by ClinicalTrials.gov.
- 28 Jul 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.